We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
377 result(s) found, displaying 291 to 300
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CISATRACURIUM JUNO cisatracurium (as besilate) 150mg/30mL Solution for Injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CISATRACURIUM JUNO cisatracurium (as besilate) 10mg/5mL Solution for Injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for CISATRACURIUM JUNO Cisatracurium besilate 5mg/2.5mL Solution for Injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NORADRENALINE JUNO noradrenaline (norepinephrine) (as acid tartrate) 2 mg/2 mL concentrated solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NORADRENALINE JUNO noradrenaline (norepinephrine) (as acid tartrate) 4 mg/4 mL concentrated solution for injection ampoule.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIVALIRUDIN JUNO bivalirudin (as trifluoroacetate) 250mg Powder for Injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for BIVALIRUDIN AC bivalirudin (as trifluoroacetate) 250mg Powder for Injection vial.
-
Prescription medicine registrationActive ingredients: Adenosine.
-
Cancellation by sponsorRequested by Juno Pharmaceuticals Pty Ltd
-
Cancellation by sponsorRequested by Juno Pharmaceuticals Pty Ltd